1. Home
  2. MEOH vs APLS Comparison

MEOH vs APLS Comparison

Compare MEOH & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methanex Corporation

MEOH

Methanex Corporation

HOLD

Current Price

$48.67

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$22.01

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEOH
APLS
Founded
1968
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
MEOH
APLS
Price
$48.67
$22.01
Analyst Decision
Buy
Buy
Analyst Count
9
20
Target Price
$48.11
$33.21
AVG Volume (30 Days)
512.4K
2.7M
Earning Date
03-05-2026
02-27-2026
Dividend Yield
1.54%
N/A
EPS Growth
40.35
N/A
EPS
2.98
0.36
Revenue
$3,569,374,000.00
$1,016,397,000.00
Revenue This Year
$1.99
$28.88
Revenue Next Year
$12.55
N/A
P/E Ratio
$16.11
$61.43
Revenue Growth
N/A
42.11
52 Week Low
$25.46
$16.10
52 Week High
$54.49
$31.17

Technical Indicators

Market Signals
Indicator
MEOH
APLS
Relative Strength Index (RSI) 74.31 45.25
Support Level $44.78 $19.26
Resistance Level $49.36 $22.24
Average True Range (ATR) 1.57 1.50
MACD 0.17 -0.34
Stochastic Oscillator 90.80 33.50

Price Performance

Historical Comparison
MEOH
APLS

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: